| (6bR,12bR)-6bβ,12bβ-Dihydro-3,3-dimethyl-11-(3-methyl-2-butenyl)-3H,7H-furo[3,2-c:5,4-f']bis[1]benzopyran-10-ol | (6bR,12bR)-6bβ,12bβ-Dihydro-3,3-dimethyl-11-(3-methyl-2-butenyl)-3H,7H-furo[3,2-c:5,4-f']bis[1]benzopyran-10-ol | 26992-37-0 |
| (6bR,14bR)-6b,12,13,14b-Tetrahydro-3,3,11,11-tetramethyl-3H,7H,11H-[1]benzopyrano[6',5':4,5]furo[3,2-c]pyrano[3,2-g][1]benzopyran | (6bR,14bR)-6b,12,13,14b-Tetrahydro-3,3,11,11-tetramethyl-3H,7H,11H-[1]benzopyrano[6',5':4,5]furo[3,2-c]pyrano[3,2-g][1]benzopyran | 26992-36-9 |
| 8-BR-CGMP | 8-BR-CGMP | 31356-94-2 |
| (11BR, 11'BR)-4,4'-(9,9-DIMETHYL-9H-XAN& | (11BR, 11'BR)-4,4'-(9,9-DIMETHYL-9H-XAN& | 349114-63-2 |
| brazzein | brazzein | |
| 5-((76)Br)bromo-3-((2-azetidinyl)methoxy)pyridine | 5-((76)Br)bromo-3-((2-azetidinyl)methoxy)pyridine | |
| (11BR, 11'BR)-4,4'-(OXYDI-2,1-PHENYLENE& | (11BR, 11'BR)-4,4'-(OXYDI-2,1-PHENYLENE& | 391860-55-2 |
| BR-CH2-PAM RESIN | BR-CH2-PAM RESIN | |
| (11bR,11'bR)-4,4'-(1S,2S)-1,2-cyclohexanediylbis[4,5-dihydro-H-Dinaphth[2,1-c:1',2'-e]azepine | (11bR,11'bR)-4,4'-(1S,2S)-1,2-cyclohexanediylbis[4,5-dihydro-H-Dinaphth[2,1-c:1',2'-e]azepine | 524941-64-8 |
| 11bR,11'bR)- 4,4'-[(1S,2S)-1,2-diphenyl-1,2-ethanediyl]bis[4,5-dihydro-H-Dinaphth[2,1-c:1',2'-e]azepine | 11bR,11'bR)- 4,4'-[(1S,2S)-1,2-diphenyl-1,2-ethanediyl]bis[4,5-dihydro-H-Dinaphth[2,1-c:1',2'-e]azepine | 1256952-84-7 |
| (4bR)-4bα,6,7,8-Tetrahydro-8α-(4-hydroxy-3,5-dimethoxyphenyl)-7aH-furo[2',3':1,2]indeno[5,6-d]-1,3-dioxole-7aα-carboxylic acid methyl ester | (4bR)-4bα,6,7,8-Tetrahydro-8α-(4-hydroxy-3,5-dimethoxyphenyl)-7aH-furo[2',3':1,2]indeno[5,6-d]-1,3-dioxole-7aα-carboxylic acid methyl ester | |
| (12bR)-3,4,8,12b-Tetrahydro-11-chloro-12bα-phenyl-2H-[1,3]oxazino[3,2-d][1,4]benzodiazepin-7(6H)-one | (12bR)-3,4,8,12b-Tetrahydro-11-chloro-12bα-phenyl-2H-[1,3]oxazino[3,2-d][1,4]benzodiazepin-7(6H)-one | |
| (4bR)-4bα,6,7,8-Tetrahydro-8α-(3,4,5-trimethoxyphenyl)-7aH-furo[2',3':1,2]indeno[5,6-d]-1,3-dioxole-7aα-carboxylic acid methyl ester | (4bR)-4bα,6,7,8-Tetrahydro-8α-(3,4,5-trimethoxyphenyl)-7aH-furo[2',3':1,2]indeno[5,6-d]-1,3-dioxole-7aα-carboxylic acid methyl ester | |
| (12bR)-3,4,8,12b-Tetrahydro-8-methyl-12bα-phenyl-2H-[1,3]oxazino[3,2-d][1,4]benzodiazepin-7(6H)-one | (12bR)-3,4,8,12b-Tetrahydro-8-methyl-12bα-phenyl-2H-[1,3]oxazino[3,2-d][1,4]benzodiazepin-7(6H)-one | |
| (12bR)-6,7,12bα,13-Tetrahydro-13β-methyl-4H-bis[1,3]benzodioxolo[5,6-a:4',5'-g]quinolizine | (12bR)-6,7,12bα,13-Tetrahydro-13β-methyl-4H-bis[1,3]benzodioxolo[5,6-a:4',5'-g]quinolizine | |
| (12bR)-3,4,8,12b-Tetrahydro-12bα-methyl-2H-[1,3]oxazino[3,2-d][1,4]benzodiazepin-7(6H)-one | (12bR)-3,4,8,12b-Tetrahydro-12bα-methyl-2H-[1,3]oxazino[3,2-d][1,4]benzodiazepin-7(6H)-one | |
| (12bR)-3,4,8,12b-Tetrahydro-2H-[1,3]oxazino[3,2-d][1,4]benzodiazepin-7(6H)-one | (12bR)-3,4,8,12b-Tetrahydro-2H-[1,3]oxazino[3,2-d][1,4]benzodiazepin-7(6H)-one | |
| (12bR)-3,4,8,12b-Tetrahydro-12bα-phenyl-2H-[1,3]oxazino[3,2-d][1,4]benzodiazepin-7(6H)-one | (12bR)-3,4,8,12b-Tetrahydro-12bα-phenyl-2H-[1,3]oxazino[3,2-d][1,4]benzodiazepin-7(6H)-one | |
| BRD-8, aa25-75 (SMAP, p120, Bromodomain containing 8, SMAP, Skeletal Muscle Abundant Protein, Thyroid hormone receptor coactivating protein p120)
| BRD-8, aa25-75 (SMAP, p120, Bromodomain containing 8, SMAP, Skeletal Muscle Abundant Protein, Thyroid hormone receptor coactivating protein p120)
| |
| BRD-8, aa200-250 (SMAP, p120, Bromodomain containing 8, Skeletal Muscle Abundant Protein, Thyroid hormone receptor coactivating protein p120)
| BRD-8, aa200-250 (SMAP, p120, Bromodomain containing 8, Skeletal Muscle Abundant Protein, Thyroid hormone receptor coactivating protein p120)
| |
| BpvUI | BpvUI | |
| 5-BR-4-CL-3-IND-P,4-TOLUIDIN | 5-BR-4-CL-3-IND-P,4-TOLUIDIN | |
| 5-BR-4-CL-3-IND-P,4-TOL.,LSG | 5-BR-4-CL-3-IND-P,4-TOL.,LSG | |
| Bpv98, Usp24 | Bpv98, Usp24 | |
| 8Br-dATP
| 8Br-dATP
| |
| BRD2 bromodomain 2 (human recombinant) | BRD2 bromodomain 2 (human recombinant) | |
| BRD2 bromodomain 1 (human recombinant) | BRD2 bromodomain 1 (human recombinant) | |
| BRD4 bromodomain 2 (human recombinant) | BRD4 bromodomain 2 (human recombinant) | |
| BRD1 bromodomain (human recombinant) | BRD1 bromodomain (human recombinant) | |
| BRD4 bromodomain 1 (human recombinant) | BRD4 bromodomain 1 (human recombinant) | |
| BRD2 bromodomains 1 and 2 (human recombinant) | BRD2 bromodomains 1 and 2 (human recombinant) | |
| BRD4 bromodomains 1 and 2 (human recombinant) | BRD4 bromodomains 1 and 2 (human recombinant) | |
| 0.5BR-7BV 0.5UL SYRINGE | 0.5BR-7BV 0.5UL SYRINGE | |
| 1BR-5BV 1UL SYRINGE | 1BR-5BV 1UL SYRINGE | |
| 1BR-7BV 1UL SYRINGE | 1BR-7BV 1UL SYRINGE | |
| 5BR-5BV 5UL SYRINGE | 5BR-5BV 5UL SYRINGE | |
| 5BR-7BV 5UL SYRINGE | 5BR-7BV 5UL SYRINGE | |
| BRDG1 protein | BRDG1 protein | |
| (11bR)-2,6-Di-9-anthracenyl-4-hydroxy-dinaphtho[2,1-d:1μ,2μ-f][1,3,2]dioxaphosphepin-4-oxide | (11bR)-2,6-Di-9-anthracenyl-4-hydroxy-dinaphtho[2,1-d:1μ,2μ-f][1,3,2]dioxaphosphepin-4-oxide | 361342-51-0 |
| 2-[(11bR)-3,5-dihydro-4H-dinaphtho[2,1-c:1',2'-e]phosphepin-4-yl]ethyl]amine, min. 97 | 2-[(11bR)-3,5-dihydro-4H-dinaphtho[2,1-c:1',2'-e]phosphepin-4-yl]ethyl]amine, min. 97% | 1092064-00-0 |
| BRD4/HUNK1 Polyclonal Antibody | BRD4/HUNK1 Polyclonal Antibody | |
| 1-(11bR)-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl- Pyrrolidine | 1-(11bR)-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl- Pyrrolidine | 736142-26-0 |
| 6-BR-3,17-DIOXOETIOALLOCHOLANE | 6-BR-3,17-DIOXOETIOALLOCHOLANE | |
| (11bR)-2,6-Di-9-phenanthrenyl-4-hydroxy-dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-oxide | (11bR)-2,6-Di-9-phenanthrenyl-4-hydroxy-dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-oxide | 864943-22-6 |
| BREADSTICK | BREADSTICK | |
| BREADSTICKS | BREADSTICKS | |
| BREADFRUIT | BREADFRUIT | |
| BREADIMPROVERS | BREADIMPROVERS | |
| BREADFIBRE | BREADFIBRE | |
| BREADCRUST | BREADCRUST | |
| BREAD | BREAD | |
| BREADWHEAT | BREADWHEAT | |
| BREADCRUMB | BREADCRUMB | |
| BREADFRUITWOOD | BREADFRUITWOOD | |
| BREADCRUMBS | BREADCRUMBS | |
| BREAD FLAVOUR | BREAD FLAVOUR | |
| BREAKSEAL FLASK (PYREX) (Code BS) | BREAKSEAL FLASK (PYREX) (Code BS) | |
| BreakFluid | BreakFluid | |
| BREAK-THRU S 240 | BREAK-THRU S 240 | |
| Breaker | Breaker | |
| BREAK-FREECLP | BREAK-FREECLP | |
| BREAKFASTCEREALS | BREAKFASTCEREALS | |
| BREAKFASTSAUSAGE | BREAKFASTSAUSAGE | |
| BREAKFASTCEREAL | BREAKFASTCEREAL | |
| BREAM IGF-I PAGRUS AURATUS | BREAM IGF-I PAGRUS AURATUS | |
| BREAM | BREAM | |
| BREAM GROWTH HORMONE ACANTHOPAGRUS BUTCHERI | BREAM GROWTH HORMONE ACANTHOPAGRUS BUTCHERI | |
| BRE Antibody Panel (Brain and Reproductive Organ-expressed, TNFRSF1A Modulator)
| BRE Antibody Panel (Brain and Reproductive Organ-expressed, TNFRSF1A Modulator)
| |
| BPW VEGITONE | BPW VEGITONE | |
| BREAST | BREAST | |
| BREASTCANCER | BREASTCANCER | |
| Breast Cancer Protein (BCRP), Clone: BXP-21, Mab anti-
| Breast Cancer Protein (BCRP), Clone: BXP-21, Mab anti-
| |
| Breast Cancer Resistance Protein (Bcrp), Abcg2, Clone: BXP-53, Mab anti-
| Breast Cancer Resistance Protein (Bcrp), Abcg2, Clone: BXP-53, Mab anti-
| |
| Breast Cancer Anti-Estrogen Resistance 3 (BCAR3), NSP2, SH2D3B, Goat anti-
| Breast Cancer Anti-Estrogen Resistance 3 (BCAR3), NSP2, SH2D3B, Goat anti-
| |
| Breast Tumor Associated Marker (BTAM) 15- Ready to UseDetection System
| Breast Tumor Associated Marker (BTAM) 15- Ready to UseDetection System
| |
| Breast Carcinoma (ER+/PgR+)(Human Single-Tissue Section Slides)
| Breast Carcinoma (ER+/PgR+)(Human Single-Tissue Section Slides)
| |
| Breast Cancer Resistance Protein (BCRP), ABCG2, Clone: BXP-21, Mab anti-Human, frozen/paraffin, IH/WB
| Breast Cancer Resistance Protein (BCRP), ABCG2, Clone: BXP-21, Mab anti-Human, frozen/paraffin, IH/WB
| |
| Breast Normal (Human Single-Tissue Section Slides)
| Breast Normal (Human Single-Tissue Section Slides)
| |
| Breast Cancer Protein (BCRP), ABCG2, Clone: BXP-34, Mab anti-
| Breast Cancer Protein (BCRP), ABCG2, Clone: BXP-34, Mab anti-
| |
| breast-swelling cream | breast-swelling cream | |
| breast-swelling beauty soap | breast-swelling beauty soap | |
| Breast Cancer Resistance Protein (BCRP)
| Breast Cancer Resistance Protein (BCRP)
| |
| Breast Tumor Cell Pellet | Breast Tumor Cell Pellet | |
| BREAST TUMOR KINASE ACTIVE HUMAN | BREAST TUMOR KINASE ACTIVE HUMAN | |
| Breast Tumor Associated Marker (BTAM) 15
| Breast Tumor Associated Marker (BTAM) 15
| |
| Breast Tumor Associated Marker (BTAM) 15 1
| Breast Tumor Associated Marker (BTAM) 15 1
| |
| Breast Cancer Resistance Protein (Bcrp), Abcg2, Clone: BXP-9, Mab anti-
| Breast Cancer Resistance Protein (Bcrp), Abcg2, Clone: BXP-9, Mab anti-
| |
| breast cancer-associated antigen 225 | breast cancer-associated antigen 225 | |
| breast-cancer metastasis suppressor 1 | breast-cancer metastasis suppressor 1 | |
| breast cancer resistance protein | breast cancer resistance protein | |
| breast basic conserved protein | breast basic conserved protein | |
| breast cancer-associated antigen 200 | breast cancer-associated antigen 200 | |
| BREASTIMPLANTS | BREASTIMPLANTS | |
| BREASTFED | BREASTFED | |
| BREASTMILK | BREASTMILK | |
| BREASTFEEDING | BREASTFEEDING | |
| Bpy (Bipy) 2,2’-bipyridyl | Bpy (Bipy) 2,2’-bipyridyl | |
| BREATH TEST ADAPTOR SET | BREATH TEST ADAPTOR SET | |
| breathless protein | breathless protein | |
| Breathable Sealing Membrane | Breathable Sealing Membrane | |